Nobuhiro Tsukada

Subcutaneous (SC) Isatuximab Administration by an On-Body Delivery System (OBDS) in Combination with Pomalidomide-Dexamethasone (Pd) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients: Interim Phase 1b Study Results

Introduction:SC Isa delivery would optimize convenience of administration. Prior results showed SC Isa administered by syringe pump has efficacy and safety comparable to IV Isa; recommend...

Hang Quach ;

Gurdeep Parmar ;

Nobuhiro Tsukada ;

Kazatuka Sunami ;

Albert Oriol ;

Pierre Bories ;

Enrique M. Ocio ;

Chatchada Karanes ;

Sumit Madan ;

Dorothee Semiond ;

Marlene Inchauspe ;

Sandrine Mace ;

Florence Suzan ;

Phillippe Moreau ;

M.H. Prince ;

11/04/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Nobuhiro Tsukada

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products